Literature DB >> 34132138

External limiting membrane and ellipsoid zone structural integrity in diabetic macular edema.

Sandeep Saxena1, Carsten H Meyer2, Levent Akduman3.   

Abstract

The external limiting membrane (ELM) and ellipsoid zone (EZ) can be observed exquisitely by SD-OCT. In diabetic macular edema (DME), dysfunction of mitochondria, represented by the EZ in the foveal photoreceptors results in reduced visual acuity (VA). An increase in VEGF was found to correlate with increased severity of DR, increased central subfield thickness (CST), and sequential disruption of ELM and EZ. The mechanism of ELM and EZ restoration after anti-VEGF therapy in DME has been discovered. The ELM restores first followed by EZ restoration. Thus, authors have discovered and established ELM as a novel retinal structural barrier.

Entities:  

Keywords:  Diabetic macular edema; anatomy/biochemistry/physiology; diabetic retinopathy; retina - medical therapies; techniques of retinal examination

Mesh:

Year:  2021        PMID: 34132138     DOI: 10.1177/11206721211026106

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  4 in total

1.  OCT-Based Biomarkers are Associated with Systemic Inflammation in Patients with Treatment-Naïve Diabetic Macular Edema.

Authors:  Jingxin Zhou; Siyuan Song; Yi Zhang; Kai Jin; Juan Ye
Journal:  Ophthalmol Ther       Date:  2022-09-27

2.  Changes of Optical Coherence Tomography Biomarkers in Macular Edema Secondary to Retinal Vein Occlusion After Anti-VEGF and Anti-Inflammatory Therapies.

Authors:  Xuefei Ding; Yijun Hu; Honghua Yu; Qiuming Li
Journal:  Drug Des Devel Ther       Date:  2022-03-15       Impact factor: 4.162

3.  Structural-vascular-functional correlation in type 2 non-proliferative macular telangiectasia.

Authors:  Ramesh Venkatesh; Nikitha Gurram Reddy; Pranjal Mishra; Naresh Kumar Yadav; Jay Chhablani
Journal:  Int J Retina Vitreous       Date:  2022-08-26

4.  Factors associated with the recurrence of choroidal neovascularization in pathologic myopia.

Authors:  Ruixia Jing; Yuxia Bo; Lei Gao; Zhen Wang
Journal:  Front Med (Lausanne)       Date:  2022-09-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.